Cerecor, Inc.
Records under this name other than patents Cerecor, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 9 of 9 · Back to Cerecor, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,245,396 | Inhalation Devices and Systems and Methods Including the Same Formerly held In force · Low confidence | In force | Low confidence | |
| US 10,202,363 | Compounds, Compositions and Methods Formerly held In force · High confidence | In force | High confidence | |
| US 10,710,976 | Compounds, Compositions and Methods Formerly held In force · High confidence | In force | High confidence | |
| US 11,479,542 | Compounds, Compositions and Methods Formerly held In force · High confidence | In force | High confidence | |
| US 12,410,153 | Compounds, Compositions and Methods Held by another company In force · Low confidence | In force | Low confidence | |
| US 10,745,435 | Nucleic Acid Prodrugs Formerly held In force · High confidence | In force | High confidence | |
| US 11,479,576 | Nucleic Acid Prodrugs Formerly held In force · High confidence | In force | High confidence | |
| US 9,364,622 | Inhalation devices and systems and methods including the same Lapsed on the fee record Ended Jun 14, 2024 · USPTO record | Lapsed on the fee record | Ended Jun 14, 2024 | USPTO record |
| US 8,501,816 | Antitussive Compositions Comprising Memantine Formerly held Lapsed on the fee record Ended Aug 6, 2017 · High confidence | Lapsed on the fee record | Ended Aug 6, 2017 | High confidence |